Calling All Leaders
New from Pharm Exec: a blog, expanded tech and deals coverage, and a new awards program for emerging pharma leaders
Rights to Japan: Q&A with Steve Engen, Japan Bridge
Global marketing strategies and the business opportunities in Japan
Saving Sales
With sales forces shrinking, how does the industry combine new technologies with old-fashioned face time to maximize sales?
Funding Follies at FDA
Congress blocked DTC user fees, Reagan-Udall, field force reforms while slightly bumping FDA's budget
Out of the Black Box: Marketing a Product with a Warning Box
A black-box warning needn't spell doom for your product. Here's how to take the good with the bad and end up on top.
Wholesale Change: UK Responds to the Single-Supplier Practice
Will the sole-wholesaler approach mean higher costs for NHS?
Brand of the Year 2008
With Chantix, Pfizer combined inspired drug design with innovative customer-focused marketing to make the first real medical assault on nicotine addiction.
Basic Training: Trends in Learning & Development Departments
Can pharma take its talent-and its earning potential-to the next level with employee education?
FluTube: What Pharma Can Learn from Novartis' YouTube Campaign
Novartis and Cadient served up a very successful unbranded campaign on YouTube. Pharma should take note of this Web 2.0 victory.
Fight Resistance
US officials think they can control MRSA and other "superbugs," but dangerous bacteria know no boundaries. What does the world do when its drugs stop working?
Big Deals
Many say licensing is the new R&D. We've rounded up the unions to watch from the third quarter of 2007.
